gp160, a tissue-specific marker for insulin-activated glucose transport

Area of Science:

• Cell Biology
• Molecular Endocrinology
• Biochemistry

Background:

• Insulin regulates glucose uptake in adipocytes primarily through the translocation of glucose transporter type 4 (GLUT4) to the cell surface.
• The precise molecular mechanisms governing insulin-stimulated GLUT4 trafficking are not fully elucidated.
• Identifying novel proteins involved in this pathway can provide further insights into glucose homeostasis.

Purpose of the Study:

• To isolate and characterize a novel M(r) 160,000 glycoprotein involved in insulin-stimulated glucose transport.
• To determine the subcellular localization and distribution of this glycoprotein in relation to GLUT4.
• To investigate the tissue-specific expression of the identified glycoprotein.

Main Methods:

• Partial protein sequencing of the M(r) 160,000 glycoprotein.
• Generation of an antipeptide antibody against the novel glycoprotein (gp160).
• Western blotting of fractionated adipocyte membranes.
• Vesicle adsorption assays using anti-GLUT4 antibodies.
• Sucrose velocity and density gradient centrifugation of microsomal vesicles.

Main Results:

• A M(r) 160,000 glycoprotein (gp160) was isolated and partially sequenced.
• An antibody against gp160 recognized a protein with identical subcellular distribution to GLUT4 in rat adipocytes.
• GLUT4 and gp160 were found to be completely colocalized in fat cells by multiple criteria.
• gp160 expression was detected exclusively in adipose tissue, cardiac muscle, and skeletal muscle.

Conclusions:

• gp160 is a novel marker for insulin-sensitive glucose transport, exhibiting identical trafficking dynamics to GLUT4.
• The colocalization of gp160 and GLUT4 suggests a potential role for gp160 in the GLUT4 translocation machinery.
• Further investigation of gp160 at the protein and DNA levels may elucidate mechanisms of insulin action and tissue-specific GLUT4 expression.